Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for bleeding with DMPA
NCT01254799Phase 3Completed
- Start
- Jan 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of doxycycline in Abnormal uterine bleeding (AUB). Primary endpoint: Stoppage of bleeding within 7 days. Started Jan 2008; status: completed.
02
Drugs
doxycycline
03
Conditions
Abnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on NCT01254799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01254799.